Assessing the value of CAN-gene mutations using MALDI-TOF MS

Author： Kohler Corina   Tavelin Björn   Fan Alex   Radpour Ramin   Barekati Zeinab   Levi Fabio   Zhong Xiao   Lenner Per   Toniolo Paolo  

Publisher： Springer Publishing Company

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.137, Iss.8, 2011-08, pp. : 1239-1244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Identification of serum biomarkers for ovarian cancer using MALDI-TOF-MS combined with magnetic beads

By Wu Shengjun  

International Journal of Clinical Oncology, Vol. 17, Iss. 2, 2012-04 ,pp. : 89-95

Springer Publishing Company

Access to resources Recommend Favorite

Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry

By Graña B.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 573-579

Springer Publishing Company

Access to resources Recommend Favorite

Study of distinct protein profiles for early diagnosis of NSCLC using LCM and SELDI-TOF-MS

By Yang Shuanying   Nan Yandong   Tian Yingxuan   Zhang Wei   Zhou Bin   Bu Lina   Huo Shufen   Chen Guoan   Yu Jiekai   Zheng Shu  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 380-386

Humana Press, Inc

Access to resources Recommend Favorite

Serum biomarker screening for the diagnosis of early gastric cancer using SELDI-TOF-MS

By      

Molecular Medicine Reports, Vol. 5, Iss. 6, 2012-01 ,pp. : 1531-1535

Spandidos Publications

Access to resources Recommend Favorite

Discovery of serum biomarkers in astrocytoma by SELDI–TOF MS and proteinchip technology

By Zhang Haishi   Wu Gang   Tu Hong   Huang Fengping  

Journal of Neuro-Oncology, Vol. 84, Iss. 3, 2007-09 ,pp. : 315-323

Springer Publishing Company

Access to resources Recommend Favorite